Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 17, 2020 07:00 ET | Source: Mateon Therapeutics, Inc.

MATEON THERAPEUTICS REPORTS SECOND QUARTER 2020 FINANCIAL RESULTS

AGOURA HILLS, Calif., Aug. 17, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics (OTC.QB: MATN), a leading developer of TGF-β therapeutics, announced financial results for the second quarter ended June...
June 29, 2020 07:00 ET | Source: Mateon Therapeutics, Inc.

MATEON ANNOUNCES $2 MILLION FINANCING WITH GOLDEN MOUNTAIN PARTNERS TO CONDUCT CLINICAL TRIAL OF OT-101 AGAINST COVID19

AGOURA HILLS, Calif., June 29, 2020 (GLOBE NEWSWIRE) -- Mateon Therapeutics, Inc. (“Mateon” or the “Company”) (OTCQB:MATN) announces it has secured a $2 million in debt financing with Golden...
June 22, 2020 08:00 ET | Source: Mateon Therapeutics, Inc.

MATEON AND GMP COMPLETED RESEARCH AND SERVICE AGREEMENT

- Mateon and GMP to proceed to clinical development of OT-101 and Artemisin and other antisense drug candidates against COVID-19 AGOURA HILLS, Calif., June 22, 2020 (GLOBE NEWSWIRE) --...